HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 148 filers reported holding HERON THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 3.08 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $86,603 | -42.7% | 57,353 | -5.2% | 0.00% | – |
| Q4 2022 | $151,225 | -31.3% | 60,490 | +16.2% | 0.00% | -100.0% |
| Q3 2022 | $220,000 | +77.4% | 52,041 | +16.8% | 0.00% | – |
| Q2 2022 | $124,000 | -54.2% | 44,554 | -5.9% | 0.00% | -100.0% |
| Q1 2022 | $271,000 | -39.9% | 47,364 | -4.2% | 0.00% | 0.0% |
| Q4 2021 | $451,000 | +0.2% | 49,452 | +17.5% | 0.00% | 0.0% |
| Q3 2021 | $450,000 | -21.1% | 42,094 | +14.6% | 0.00% | 0.0% |
| Q2 2021 | $570,000 | +54.5% | 36,719 | +61.4% | 0.00% | 0.0% |
| Q1 2021 | $369,000 | +10.1% | 22,757 | +43.6% | 0.00% | 0.0% |
| Q4 2020 | $335,000 | +42.6% | 15,850 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $235,000 | +9.8% | 15,850 | +9.0% | 0.00% | 0.0% |
| Q2 2020 | $214,000 | – | 14,537 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |